핵심 개념
Early-stage cutaneous lymphoma presents challenges in diagnosis and treatment, emphasizing the need for improved prognostic tools and personalized therapies.
통계
An estimated 20%-30% of patients with CL progress to an advanced stage.
5-year survival rate in advanced CL patients can be as low as 30%.
Patients with a TCF greater than 25% are more likely to have aggressive disease.
인용구
"Cutaneous lymphoma is difficult to diagnose. Even when it is properly diagnosed, we do not have widespread use of biomarkers to predict if a patient will progress to a dangerous disease state." - Patrick M. Brunner, MD, MSc
"Treatments are palliative, they're just suppressing the disease. We definitely need better and safer treatments for our patients." - Patrick M. Brunner, MD, MSc